Gastric mucosal defense factor biosynthesis

Gastric mucosal defense factor biosynthesis encompasses the synthesis and regulation of a diverse group of molecules, including mucins, prostaglandins, trefoil peptides (TFF1, TFF2), regenerating protein (RegI), β-defensins, nitric oxide, antioxidants, and growth factors, which act together to maintain gastric mucosal integrity. These factors enable the mucosa to withstand continuous exposure to acid, digestive enzymes, oxidative stress, and microbial pathogens. Drugs such as proton pump inhibitors and misoprostol help protect the gastric mucosa by enhancing or supplementing these defense mechanisms. Impairment of these biosynthetic pathways leads to increased susceptibility to ulcers and injury, particularly in settings such as NSAID use or infection[1][2][3][4]. To obtain information about specific therapeutic targets within this process, such as "Mucin MUC2," "Regenerating protein 1 (RegI)," "Trefoil factor family peptides," or "β-Defensin 3," refer to the individual molecule names and their respective biology.

Involves the enhancement of mucus barrier, promotion of epithelial cell proliferation, stimulation of prostaglandin synthesis, antioxidant effects, and modulation of immune defenses.